Early cost-effectiveness of tumor infiltrating lymphocytes (TIL) for second line treatment in advanced melanoma: a model-based economic evaluation
Pre-publication versions of this article are available by contacting email@example.com.
|22 Nov 2017||Submitted||Original manuscript|
|30 Aug 2017||Reviewed||Reviewer Report - Chun-ru Chien|
|10 Sep 2017||Reviewed||Reviewer Report - Edward Wilson|
|24 Jan 2018||Reviewed||Reviewer Report - Rei Goto|
|3 Apr 2018||Reviewed||Reviewer Report - Christine Kohn|
|2 Jun 2018||Author responded||Author comments - Valesca Retèl|
|Resubmission - Version 2|
|2 Jun 2018||Submitted||Manuscript version 2|
|3 Jul 2018||Reviewed||Reviewer Report - Rei Goto|
|24 Aug 2018||Author responded||Author comments - Valesca Retèl|
|Resubmission - Version 3|
|24 Aug 2018||Submitted||Manuscript version 3|
|3 Sep 2018||Editorially accepted|
|15 Sep 2018||Article published||10.1186/s12885-018-4788-5|
How does Open Peer Review work?
Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting firstname.lastname@example.org.
You can find further information about the peer review system here.